BSLK

Bolt Projects is a pre-commercial "Vegan Silk" (b-silk/xl-silk) biomaterials company that reverse-merged into a SPAC (Golden Arrow) in August 2024, and the numbers describe a business in collapse, not a startup scaling. FY2024 revenue fell 60.1% to just $1.37M — the wrong direction for a company whose entire thesis is commercialization — while it burned $16.1M in operating cash and posted a -$65.4M net loss. Gross profit is actually negative (-$93K, -6.8% margin): the company loses money on the product before a single dollar of the $6.25M R&D or corporate overhead. Operating margin of -3,030% and net margin of -4,763% are not distressed-value ratios, they are the arithmetic of a company with almost no revenue and a full corporate cost structure.

The balance sheet is past stress into insolvency territory: stockholders' equity is -$8.61M (liabilities/equity -2.42x), retained-earnings deficit is -$462M, and only $3.51M of cash sits against $13.2M of long-term debt and an ~$16M annual cash burn — well under a year of runway absent dilution. The disclosed financing lifelines confirm desperation, not strength: a February 2025 Triton agreement to sell up to only $1.5M of stock plus a warrant struck at $0.50 (50x the current $0.01 price, so effectively worthless to the company), meaning survival depends on issuing shares into a sub-penny market — massively dilutive to the 34.4M shares already out.